Relationship of Non-Invasive Arterial Stiffness Parameters with 10-Year Atherosclerotic Cardiovascular Disease Risk Score in Post-COVID-19 Patients-The Results of a Cross-Sectional Study.

Relationship of Non-Invasive Arterial Stiffness Parameters with 10-Year Atherosclerotic Cardiovascular Disease Risk Score in Post-COVID-19 Patients-The Results of a Cross-Sectional Study.

Publication date: Sep 02, 2024

This study evaluated the relationship of non-invasive arterial stiffness parameters with an individual 10-year risk of fatal and non-fatal atherosclerotic cardiovascular disease (ASCVD) events in the cohort post-coronavirus disease 2019 (COVID-19). The study group included 203 convalescents aged 60. 0 (55. 0-63. 0) and 115 (56. 7%) women. The ASCVD risk was assessed as low to moderate to very high based on medical history (for 62 participants with pre-existing ASCVD/diabetes/chronic kidney disease in the entire cohort) or calculated in percentages using the Systemic Coronary Risk Evaluation 2 (SCORE2) algorithm based on age, sex, smoking status, systolic blood pressure (BP), and non-high-density lipoprotein cholesterol (for 141 healthy participants). The stiffness index (SI) and reflection index (RI) measured by photoplethysmography, as well as pulse pressure (PP), calculated as the difference between systolic and diastolic BP, were markers of arterial stiffness. Stiffness parameters increased significantly with the increase in ASCVD risk in the entire cohort. In 30 (14. 8%) patients in the low- to moderate-risk group, the median SI was 8. 07 m/s (7. 10-8. 73), RI 51. 40% (39. 40-65. 60), and PP 45. 50 mmHg (40. 00-57. 00); in 111 (54. 7%) patients in the high-risk group, the median SI was 8. 70 m/s (7. 40-10. 03), RI 57. 20% (43. 65-68. 40), and PP 54. 00 mmHg (46. 00-60. 75); and in 62 (30. 5%) patients in the very-high-risk group, the median was SI 9. 27 m/s (7. 57-10. 44), RI 59. 00% (50. 40-72. 40), and PP 60. 00 mmHg (51. 00-67. 00). In healthy participants, the SI ≤ 9. 0 m/s (sensitivity of 92. 31%, area under the curve [AUC] 0. 686, p < 0. 001) based on the receiver operating characteristics was the most sensitive variable for discriminating low to moderate risk, and PP > 56. 0 mmHg (sensitivity of 74. 36%, AUC 0. 736, p < 0. 001) was used for discriminating very high risk. In multivariate logistic regression, younger age, female sex, PP ≤ 50 mmHg, SI ≤ 9. 0 m/s, and triglycerides < 150 mg/dL had the best relationship with low to moderate SCORE2 risk. In turn, older age, currently smoking, PP > 56. 0 mmHg, RI > 68. 6%, and diastolic BP ≥ 90 mmHg were related to very high SCORE2 risk. In conclusion, arterial stiffness is significantly related to ASCVD risk in post-COVID-19 patients and can be helpful as a single risk marker in everyday practice. Cut-off points for arterial stiffness parameters determined based on SCORE2 may help make individual decisions about implementing lifestyle changes or pharmacological treatment of ASCVD risk factors.

Open Access PDF

Concepts Keywords
Coronavirus arterial stiffness
Diabetes atherosclerotic cardiovascular diseases
Pharmacological COVID-19 disease
Photoplethysmography risk prediction

Semantics

Type Source Name
disease MESH Arterial Stiffness
disease MESH Cardiovascular Disease
disease MESH COVID-19
disease IDO history
disease MESH chronic kidney disease
disease IDO algorithm
disease IDO blood
drug DRUGBANK Cholesterol
disease MESH lifestyle
disease MESH Cardiovascular Risk Score
disease MESH Heart Failure
drug DRUGBANK Coenzyme M
disease MESH death
disease MESH chronic illnesses
disease MESH dyslipidemia
disease MESH hypertension
disease MESH arthritis
disease MESH complications
disease MESH long COVID
disease MESH syndrome
disease MESH infection
disease MESH oxidative stress
disease IDO production
disease MESH inflammation
disease MESH arteriosclerosis
disease MESH hyperglycemia
disease MESH hyperlipidemia
disease MESH obesity
drug DRUGBANK Cysteamine
disease MESH myocardial infarction

Original Article

(Visited 1 times, 1 visits today)